QUOTE AND NEWS
newratings.com  3 hrs ago  Comment 
NEW YORK, November 25 (newratings.com) - Analysts at Wells Fargo Securities initiate coverage of Hologic (ticker: HOLX) with an "outperform" rating. [more]
Market Intelligence Center  3 hrs ago  Comment 
Hologic (NasdaqNM: HOLX) opened at $14.69. So far today, the stock has hit a low of $14.57 and a high of $14.82. HOLX is now trading at $14.67, up $0.11 (0.76%). Over the last 52 weeks the stock has ranged from a low of $9.31 to a high of $17.83....
Stock Blog Hub  Nov 17  Comment 
Hologic, Inc. (HOLX) reported fourth quarter earnings of 28 cents per share, above the Zacks Consensus Estimate of 26 cents, but a couple of cents below the year-ago earnings. For fiscal 2009, the company earned $1.17 per share, a cent below the...
PR Newswire  Nov 16  Comment 
BEDFORD, Mass., Nov. 16 /PRNewswire-FirstCall/ -- Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the
Stock Blog Hub  Nov 12  Comment 
Hologic, Inc. (HOLX) reported fourth-quarter earnings of 28 cents per share, which beat the Zacks Consensus Estimate of 26 cents. The company earned 30 cents in the year-ago quarter. For full fiscal 2009, the company earned $1.17 per share, which...
PR Newswire  Nov 11  Comment 
BEDFORD, Mass., Nov. 11 /PRNewswire-FirstCall/ -- Hologic, Inc. (Nasdaq: HOLX) today announced that Jack Cumming, Chairman, will present at the NASDAQ OMX 23rd Investor Program in London on Tuesday, December 1, 2009, at 11:15am (GMT). Interested
newratings.com  Nov 11  Comment 
NEW YORK, November 10 (newratings.com) - Analysts at Jefferies & Co reiterate their "buy" rating on Hologic Inc (ticker: HOLX). The target price has been raised from $17 to $18. [more]
StreetInsider.com  Nov 9  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Hologic+%28HOLX%29+Posts+Q3+adj.-EPS+of+%240.28%2C+Tops+by+1c%3B+Guides+Q110+EPS/5089838.html for the full story.
PR Newswire  Nov 9  Comment 
BEDFORD, Mass., Nov. 9 /PRNewswire-FirstCall/ -- Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the
newratings.com  Nov 6  Comment 
NEW YORK, November 4 (newratings.com) - Analysts at Barrington Research upgrade Hologic (ticker: HOLX) from "market perform" to "outperform." The target price is set to $19. [more]
Suggest a News Source
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
Close 
Thanks for your suggestion!
 
 
TOP CONTRIBUTORS
HOLX AT A GLANCE
 
 
 
 
 
 
 
 

Hologic is a leading developer, manufacturer, and supplier of diagnostic and medical imaging systems primarily dedicated to serving the healthcare needs of women. The company focuses its resources on developing systems and subsystems offering superior image quality and diagnostic accuracy, which has resulted in capturing significant market share and customer loyalty, despite the presence of large competitors. The company's core women's healthcare business units include mammography/ breast care osteoporosis assessment and other. The mammography/ breast care products include a broad product line of breast imaging and related products, including film-based and digital mammography systems, computer-aided detection (CAD), and breast biopsy systems. Beginning in 2006, the digital detector business was combined with the mammography operating segment to better reflect how the company views its operations and manage its business. The digital detector products are a digital component for Hologic's digital mammography equipment and, to a much lesser extent, are a digital component for original equipment manufacturers to incorporate into their own equipment. The osteoporosis assessment products primarily consist of dual-energy X-ray bone densitometry systems and, to a lesser extent, an ultrasound-based osteoporosis assessment product. The other business segment includes the mini C-arm, extremity MRI, conventional general radiography service, digital general radiography systems, and AEG photoconductor materials business. Hologic also provides product service and the revenues generated are allocated to the appropriate division. Hologic's customers include hospitals, imaging clinics and private practices, many of the leading healthcare organizations in the world, and major pharmaceutical companies utilizing its products in conducting clinical trials. Based on fiscal year results ended September 29, 2007, mammography/breast care, osteoporosis assessment, and other contributed roughly 79%, 9%, and 12% respectively to total revenue. Based on geography, revenue from the U.S., Europe, Asia, and all others contributed 75%, 15%, 5%, and 5% respectively to total fiscal 2007 revenue.


A wholly-owned subsidiary of Hologic, Cytyc is a diversified diagnostic and medical device company that designs, develops, manufactures, and markets innovative and clinically effective diagnostic and surgical products. Cytyc's products cover a range of cancer and women's health applications, including cervical cancer screening, pre-term birth risk assessment, treatment of excessive menstrual bleeding, radiation treatment of early-stage breast cancer, and radiation treatment of patients with malignant brain tumors. Hologic acquired Cytyc in October 2007. Cytyc previously operated its business in three segments: domestic diagnostic products, domestic surgical products, and international, which contributed 53%, 35%, and 12% respectively to total revenue for the nine months ended September 30, 2007.




References

Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki